CPLA2 (Phospho-Ser505) Antibody
Synthesized peptide derived from human cPLA2 around the phosphorylation site of S505.
Product Specifications
Product Name Alternative
PLA2G4A; CPLA2; PLA2G4; Cytosolic phospholipase A2; cPLA2; Phospholipase A2 group IVA
UniProt
P47712
Reactivity
Human, Mouse, Rat
Immunogen
Synthesized peptide derived from human cPLA2 around the phosphorylation site of S505.
Target
Disease
Clonality
Polyclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
Approximately 1mg/ml (varies from batch to batch) . Please inquire for precise concentration.
Dilution
WB: 1/500-1/2000; IHC: 1/100-1/300; IF/ICC: 1/200-1/1000; ELISA: 1/10000
Molecular Weight
110kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Applications Notes
Modified: Phosphorylated
Tested Applications
ICC, IHC, WB
Host or Source
Rabbit
Preservative
Purified antibody in PBS with 0.05% sodium azide,0.5%rAlbumin and 50% glycerol.
Isotype
Rabbit IgG
Entrez
5321
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CRELD2, CT (CRELD2, Cysteine-rich with EGF-like domain protein 2) (MaxLight 550)
CRELD2, CT (CRELD2, Cysteine-rich with EGF-like domain protein 2) (MaxLight 550)
Recombinant Bacillus subtilis SpoIVD-associated factor A (safA)
Recombinant Bacillus subtilis SpoIVD-associated factor A (safA)